Teneligliptin as an Adjuvant Therapy in Type 2 Diabetic Management: A Prospective Observational Study

Menaka Kaliyan1,2, Prabha Thangavel2 and Senthilkumar Palaniappan1,3* Author informationArticle notesCopyright and License informationCitations Corresponding author. Correspondence: Dr. Senthilkumar Palaniappan 1Faculty of Pharmacy, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, INDIA. 2Centre for Active Pharmaceutical Ingredients, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, INDIA. Email: drsenthilkumar.p@kahedu.edu.in Received February 12, 2024; Revised March 17, 2024